Clinical trials sponsored by Jonsson Comprehensive Cancer Center

Phase breakdown

Conditions studied

Recruiting trials led by Jonsson Comprehensive Cancer Center

• 99mTc-PSMA-I&S Biodistribution in Patients With Prostate Cancer
  NCT04857502 · Phase: Early Phase 1 · Ages: No age limits stated · Sex: Male · 1 location
• A Clinic-wide Intervention (Primary Care-GI Connect) for Improving Rates of Colonoscopy After Abnormal Fecal Immunochemical Test Result in Patients at Federally Qualified Health Centers
  NCT06568016 · Phase: Not applicable (e.g. observational or device study) · Ages: No age limits stated · Sex: All (male and female) · 2 locations
• A Study to See if an iPhone Weight Management App Can Help Promote Weight Loss in Adolescents and Young Adults After a Stem Cell Transplant
  NCT04453072 · Phase: Not applicable (e.g. observational or device study) · Ages: 13 Years to 30 Years · Sex: All (male and female) · 1 location
• A Trial Comparing Screening Mammography With and Without Assistance From Artificial Intelligence for Breast Cancer Detection and Recall Rates in Adult Patients
  NCT06934239 · Phase: Phase 4 · Ages: 18 Years and older · Sex: All (male and female) · 6 locations
• AB801 in Combination With Chemotherapy and Immunotherapy for the Treatment of Patients With Borderline Resectable, Locally Advanced or Metastatic Cholangiocarcinoma or Pancreatic Cancer
  NCT07619313 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Active Surveillance for Cancer of the Prostate (ASCaP)
  NCT00949819 · Phase: Not specified · Ages: 30 Years to 85 Years · Sex: Male · 1 location
• An Investigational Scan (Flotufolastat F 18 PET/CT) for Detecting Residual or Recurrent Disease in Patients Who Completed Focal Therapy for Prostate Cancer.
  NCT07185165 · Phase: Phase 2 · Ages: 18 Years to 90 Years · Sex: Male · 1 location
• Brain Health in Breast Cancer Survivors
  NCT04297020 · Phase: Not specified · Ages: 35 Years to 65 Years · Sex: Female · 1 location
• Comparing a New PSMA Imaging Agent to MRI for Detecting Prostate Cancer, BEACON Trial
  NCT07164027 · Phase: Early Phase 1 · Ages: 18 Years to 90 Years · Sex: Male · 1 location
• Fluoxetine for the Modification of Colorectal Tumor Immune Cells Before Surgery in Patients With Colorectal Cancer
  NCT06225011 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Focal Radiation Therapy (HDR-Brachytherapy) for the Treatment of Prostate Cancer
  NCT07468903 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years and older · Sex: Male · 1 location
• High Dose-Rate Brachytherapy and Stereotactic Body Radiotherapy for the Treatment of Prostate Adenocarcinoma
  NCT04945642 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Hormone Therapy (Apalutamide) and Image-guided Stereotactic Body Radiation Therapy for the Treatment of Patients With Prostate Cancer, HEATWAVE Trial
  NCT06067269 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Image-Guidance and Online Adaptation With Stereotactic Body Radiation Therapy for the Treatment of Localized Prostate Cancer, MANTICORE Trial
  NCT07276438 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Male · 1 location
• Integrating Quantitative MRI and Artificial Intelligence to Improve Prostate Cancer Classification
  NCT04765150 · Phase: Not specified · Ages: 18 Years and older · Sex: Male · 1 location
• Phase 2 Randomized Trial of Flexible Dosing Schedule of 177Lu-PSMA-617 for the Treatment of Metastatic Castration-Resistant Prostate Cancer (FLEX-MRT)
  NCT06216249 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Male · 1 location
• Short Course Radiation Therapy and Combination Chemotherapy for the Treatment of Stage II-III Rectal Cancer
  NCT04703101 · Phase: Phase 1 · Ages: 18 Years and older · Sex: All (male and female) · 1 location
• Testing the Safety of Dapagliflozin Prior to Surgery for the Treatment of Patients With Stage IA Lung Adenocarcinoma
  NCT07235280 · Phase: Early Phase 1 · Ages: 22 Years and older · Sex: All (male and female) · 1 location
• Trastuzumab Deruxtecan Alone or in Combination With Anastrozole for the Treatment of Early Stage HER2 Low, Hormone Receptor Positive Breast Cancer
  NCT04553770 · Phase: Phase 2 · Ages: 18 Years and older · Sex: All (male and female) · 9 locations
• Utilizing Advocates and Supporters to Increase Lung Cancer Screening Rates in Eligible Participants
  NCT05978128 · Phase: Not applicable (e.g. observational or device study) · Ages: 40 Years to 80 Years · Sex: All (male and female) · 2 locations
• Vascular Optimized Radiotherapy Tuned to Critical Structures for Erectile Function Using High-Precision X-Ray Treatment
  NCT07293585 · Phase: Phase 3 · Ages: 18 Years and older · Sex: Male · 1 location
• Virtual Reality vs. Music Relaxation for Reducing Anxiety and Pain During Breast Biopsies
  NCT07310004 · Phase: Not applicable (e.g. observational or device study) · Ages: 18 Years and older · Sex: Female · 1 location

Common questions

How many trials is Jonsson Comprehensive Cancer Center recruiting for?

Jonsson Comprehensive Cancer Center is the lead sponsor of 22 recruiting trials.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.